GR20100100508A - Ποσιμα φαρμακευτικα διαλυματα για τη θεραπεια του υποθυρεοειδισμου - Google Patents

Ποσιμα φαρμακευτικα διαλυματα για τη θεραπεια του υποθυρεοειδισμου

Info

Publication number
GR20100100508A
GR20100100508A GR20100100508A GR20100100508A GR20100100508A GR 20100100508 A GR20100100508 A GR 20100100508A GR 20100100508 A GR20100100508 A GR 20100100508A GR 20100100508 A GR20100100508 A GR 20100100508A GR 20100100508 A GR20100100508 A GR 20100100508A
Authority
GR
Greece
Prior art keywords
drinkable
hypothyroidism
treatment
pharmaceutical solutions
solutions
Prior art date
Application number
GR20100100508A
Other languages
English (en)
Inventor
Γεωργιος Λιολιος
Αγγελος Καρατζας
Ηλιας Κοτσιανης
Original Assignee
Alapis Α.Β.Ε.Ε.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alapis Α.Β.Ε.Ε., filed Critical Alapis Α.Β.Ε.Ε.,
Priority to GR20100100508A priority Critical patent/GR20100100508A/el
Publication of GR20100100508A publication Critical patent/GR20100100508A/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Σταθερά πόσιμα φαρμακευτικά διαλύματα τα οποία εύκολα μπορούν να μορφοποιηθούν σε πόσιμες σταγόνες και τα οποία περιλαμβάνουν νατριούχα λεβοθυροξίνη ως δραστικό συστατικό και έναν συνδυασμό αιθανόλης, προπυλενογλυκόλης και νερού. Τα πόσιμα διαλύματα της παρούσας εφεύρεσης παραμένουν φυσικοχημικώς σταθερά όταν αποθηκεύονται, για τουλάχιστον τρεις μήνες σε θερμοκρασία 25 βαθμοί Κελσίου και σχετικήυγρασία 60 τοις εκατό.
GR20100100508A 2010-09-10 2010-09-10 Ποσιμα φαρμακευτικα διαλυματα για τη θεραπεια του υποθυρεοειδισμου GR20100100508A (el)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20100100508A GR20100100508A (el) 2010-09-10 2010-09-10 Ποσιμα φαρμακευτικα διαλυματα για τη θεραπεια του υποθυρεοειδισμου

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20100100508A GR20100100508A (el) 2010-09-10 2010-09-10 Ποσιμα φαρμακευτικα διαλυματα για τη θεραπεια του υποθυρεοειδισμου

Publications (1)

Publication Number Publication Date
GR20100100508A true GR20100100508A (el) 2012-04-30

Family

ID=45954096

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20100100508A GR20100100508A (el) 2010-09-10 2010-09-10 Ποσιμα φαρμακευτικα διαλυματα για τη θεραπεια του υποθυρεοειδισμου

Country Status (1)

Country Link
GR (1) GR20100100508A (el)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2692340A1 (en) * 2012-08-03 2014-02-05 Verisfield (UK) Ltd. Stable pharmaceutical system (kit) for the preparation of oral solution of levothyroxine or pharmaceutically acceptable salt thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2692340A1 (en) * 2012-08-03 2014-02-05 Verisfield (UK) Ltd. Stable pharmaceutical system (kit) for the preparation of oral solution of levothyroxine or pharmaceutically acceptable salt thereof

Similar Documents

Publication Publication Date Title
PH12016500216A1 (en) Stable pharmaceutical composition and methods of using same
UA105229C2 (uk) Фармацевтичний склад
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
MY146969A (en) Dpp iv inhibitor formulations
MX348823B (es) Formulaciones estables de linaclotida.
SG171542A1 (en) Pharmaceutical composition comprising a strontium salt, vitamin d and a cyclodextrin
GEP20146015B (en) Novel acetylsalicylic acid salts
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
EA201201050A1 (ru) Пиразолы в качестве антагонистов crth2
WO2008053297A3 (en) Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa
UA103025C2 (ru) Твердая композиция лекарственного средства замедленного высвобождения
MX342947B (es) Tratamiento de diabetes tipo 2.
BR112014002940A2 (pt) uso e composição agroquímica de dibutilamidas de ácido carboxílico
NZ621484A (en) Stable anti-inflammatory solutions for injection
MX2009007265A (es) Sales, composiciones liquidas acuosas que cotienen sales de acido s-(+)-abscisico y metodos para su preparacion.
UA100394C2 (en) Lipoic acid pellet composition
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
MY148393A (en) Malate salts, and polymorphs of (3s, 5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
TN2012000105A1 (en) Spirolactam derivatives and uses of same
MX2009010483A (es) 5-oxoisoxazoles como inhibidores de lipasas y fosfolipasas.
WO2009120700A3 (en) Inhibition of dcps
WO2012075015A3 (en) Oral metronidazole pharmaceutical compositions
NO20082848L (no) Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre
EA201290485A1 (ru) Производные бензамида
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees

Effective date: 20140403